Live Analyst Rating Changes 24636 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Mike Kratky
LP

Mike Kratky

Leerink Partners
Wall Street Analyst
★★★☆☆
#2061
on 13Foresight · ranked by our own returns
52%
Success Rate
+10.2%
Average Return
16 of 31 calls profitable · -3.0% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 52% of Mike Kratky's ratings turned a profit when each position was held for 1 year — averaging +10.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

28 Buy 13 Hold 0 Sell
Mike's Stock Coverage 23 ratings · 2026-08-14
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
PODD
Insulet
 Aug 06, 2026 HOLD Strong Buy
+48.7% avg upside
32 analysts
$145.00
1.08% Downside
 +2.9% ·
BSX
Boston Scientific
 Jul 30, 2026 BUY Strong Buy
+31.1% avg upside
38 analysts
$60.00
16.17% Upside
 +11.8% ·
EW
Edwards Lifesciences
 Jul 24, 2026 BUY Strong Buy
+8.5% avg upside
34 analysts
$101.00
9.18% Upside
 +10.9% ·
ISRG
Intuitive Surgical
 Jul 17, 2026 BUY Strong Buy
+19.8% avg upside
36 analysts
$454.00
13.05% Upside
 +14.2% ·
MDT
Medtronic
 Jul 10, 2026 BUY Buy
+6.4% avg upside
38 analysts
 — +9.4% ·
PRCT
PROCEPT BioRobotics
 Jun 12, 2026 HOLD Buy
+45.3% avg upside
17 analysts
$29.00
32.12% Upside
 -15.8% ·
ZBH
Zimmer Biomet Holdings
 Apr 13, 2026 HOLD Buy
+15.1% avg upside
38 analysts
$101.00
1.38% Upside
 +5.9% ·
SYK
Stryker
 Apr 13, 2026 BUY Strong Buy
+8.2% avg upside
37 analysts
$410.00
20.10% Upside
 -1.5% ·
PEN
Penumbra
 Jan 15, 2026 HOLD Buy
+1.1% avg upside
23 analysts
$374.00
14.36% Upside
 -6.7% ·
ABT
Abbott Laboratories
 Oct 16, 2025 HOLD Strong Buy
+4.4% avg upside
36 analysts
$136.00
22.28% Upside
 -13.3% ·
INSP
Inspire Medical Systems
 Oct 14, 2025 HOLD Buy
+45.8% avg upside
21 analysts
$96.00
65.02% Upside
 -27.6% ·
VCEL
Vericel
 Oct 14, 2025 BUY Strong Buy
+6.4% avg upside
16 analysts
$48.00
7.85% Upside
 +28.0% ·
DXCM
Dexcom
 Oct 14, 2025 BUY Strong Buy
+16.1% avg upside
32 analysts
$84.00
8.12% Downside
 +35.5% ·
TNDM
Tandem Diabetes Care
 Oct 14, 2025 BUY Buy
+41.5% avg upside
29 analysts
$29.00
25.29% Upside
 +58.0% ·
CRC
California Resources Corp
 Oct 14, 2025 BUY Strong Buy
+38.5% avg upside
21 analysts
 — +12.9% ·
BBNX
Beta Bionics, Inc.
 Sep 12, 2025 BUY Strong Buy
+20.9% avg upside
14 analysts
$28.00
54.84% Upside
 -33.5% ·
AXGN
AxoGen
 Aug 25, 2025 BUY Strong Buy
-27.1% avg upside
21 analysts
$22.00
54.17% Downside
 +235.8% ·
NPCE
NeuroPace
 Aug 13, 2025 BUY Strong Buy
+24.9% avg upside
13 analysts
$18.00
23.98% Upside
 +55.7% ·
JNJ
Johnson & Johnson
 Apr 05, 2024 BUY Strong Buy
-9.2% avg upside
39 analysts
 — +3.8% ·
LLY
Eli Lilly & Co
 Oct 16, 2023 BUY Strong Buy
-14.0% avg upside
48 analysts
 — +49.6% ·
PLRX
Pliant Therapeutics
 Sep 26, 2023 BUY Buy
+1960.5% avg upside
21 analysts
$46.00
4159.30% Upside
 -33.0% ·
KYMR
Kymera Therapeutics
 May 04, 2023 HOLD Strong Buy
-7.7% avg upside
37 analysts
$31.00
72.90% Downside
 +42.5% ·
VRDN
Viridian Therapeutics
 Aug 15, 2022 BUY Strong Buy
+59.8% avg upside
32 analysts
$40.00
81.84% Upside
 -11.1% ·
🔒 18 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Mike Kratky — Frequently Asked Questions
How accurate are Mike Kratky's stock ratings?
Based on the calls 13Foresight could measure, about 52% of Mike's ratings were profitable over a one-year hold, with an average return of +10.4% per rating, or -2.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Mike ranked on 13Foresight?
Mike Kratky is currently ranked #2061 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Mike cover?
Mike most recently has ratings on PODD, BSX, EW, ISRG, MDT, PRCT, ZBH, SYK, PEN, ABT, INSP, VCEL and 11 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.